- Home
- DMLP vs OPK Comparison
DMLP vs OPK Comparison
Compare DMLP & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DMLP
- OPK
- Stock Information
- Founded
- DMLP 2003
- OPK 2007
- Country
- DMLP United States
- OPK United States
- Employees
- DMLP N/A
- OPK N/A
- Industry
- DMLP Oil & Gas Production
- OPK Biotechnology: Pharmaceutical Preparations
- Sector
- DMLP Energy
- OPK Health Care
- Exchange
- DMLP Nasdaq
- OPK Nasdaq
- Market Cap
- DMLP 1.3B
- OPK 1.1B
- IPO Year
- DMLP N/A
- OPK 1995
- Fundamental
- Price
- DMLP $27.75
- OPK $1.34
- Analyst Decision
- DMLP
- OPK Buy
- Analyst Count
- DMLP 0
- OPK 4
- Target Price
- DMLP N/A
- OPK $2.75
- AVG Volume (30 Days)
- DMLP 65.4K
- OPK 2.3M
- Earning Date
- DMLP 08-08-2025
- OPK 07-31-2025
- Dividend Yield
- DMLP 11.66%
- OPK N/A
- EPS Growth
- DMLP N/A
- OPK N/A
- EPS
- DMLP 2.03
- OPK N/A
- Revenue
- DMLP $166,824,000.00
- OPK $689,408,000.00
- Revenue This Year
- DMLP N/A
- OPK N/A
- Revenue Next Year
- DMLP N/A
- OPK $6.98
- P/E Ratio
- DMLP $13.80
- OPK N/A
- Revenue Growth
- DMLP 12.09
- OPK N/A
- 52 Week Low
- DMLP $25.84
- OPK $1.21
- 52 Week High
- DMLP $34.88
- OPK $2.04
- Technical
- Relative Strength Index (RSI)
- DMLP 52.34
- OPK 46.92
- Support Level
- DMLP $27.10
- OPK $1.34
- Resistance Level
- DMLP $28.00
- OPK $1.45
- Average True Range (ATR)
- DMLP 0.39
- OPK 0.05
- MACD
- DMLP 0.05
- OPK -0.00
- Stochastic Oscillator
- DMLP 72.22
- OPK 15.38
About DMLP Dorchester Minerals L.P. Common Units Representing Limited Partnership Interests
Dorchester Minerals LP operates as the owner of producing and non-producing crude oil and natural gas mineral, royalty, overriding royalty, net profits and leasehold interests. The company generates revenues from royalties, net profits interests, lease bonus, and others. It has leasehold interests in approximately 592 counties and parishes in around 28 states.
About OPK OPKO Health Inc.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.